ProductUpdated on 9 July 2025
Cannabinoid Medical Chewing Gum (THC/CBD) GMP & EP Compliant
About
Pharmaceutical chewing gum with cannabinoids (THC/CBD), developed as an oral medical device for controlled buccal delivery. Designed to meet European Pharmacopoeia standards (≥70% active release), it enables full-spectrum cannabinoid therapies with pharmaceutical precision and high patient compliance. Suitable for chronic pain, anxiety, insomnia, and clinical trials. Available for licensing, co-development, or CDMO partnerships
Looking for
- Other
Applies to
- Pharmaceutical industry
- Health innovation
Similar opportunities
Service
Clinical Trial Supply & Logistics Services
- Development
- Manufacturing
- Pharmaceutical industry
Marc Brehme
Founder & Managing Director at M-B-V-C
Vienna, Austria
Service
Analysis of protein-based pharmaceuticals
Marcos Engroba Pulido (He/Him)
BDM at AMSbio+pharma
Lugo, Spain